iPSC-Derived Neurons

Induced Pluripotent Stem Cells (iPSCs)

Overview

Induced Pluripotent Stem Cells (iPSCs)

Overview

Ipsc Derived Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Ipsc Derived Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@takahashi2007]

Induced pluripotent stem cells (iPSCs) are somatic cells reprogrammed to a pluripotent state through expression of specific transcription factors. They offer unprecedented opportunities for disease modeling, drug screening, and potential cell therapy in neurodegenerative diseases. [@kriks2011]

Discovery and Development

Historical Background

• 2006: Takahashi and Yamanaka generated first mouse iPSCs
• 2007: Human iPSCs derived from fibroblasts
• 2012: Shinya Yamanaka awarded Nobel Prize in Physiology or Medicine

Reprogramming Factors (Yamanaka Factors)

• OCT4 - Pluripotency maintenance
• SOX2 - Neural rosette formation
• KLF4 - Proliferation, self-renewal
• c-MYC - Metabolic reprogramming (often omitted for safety)

Alternative Factor Combinations

• OCT4 alone - lower efficiency
• LIN28 + NANOG - alternative reprogramming
• Small molecule approaches - chemical reprogramming

Generation Methods

Viral Vector Approaches

• Retroviral - integration, silencing issues
• Lentiviral - better tropism
• Sendai virus - non-integrating (TempUS)

Non-Integrating Methods

• Episomal vectors - EBNA1/oriP plasmids
• mRNA transfection - repeated delivery
• Small molecules - chemical reprogramming
• Protein transduction - direct protein delivery

Cell Sources

• Skin fibroblasts - easy access, established
• Peripheral blood mononuclear cells
• Urine-derived cells
• Mesenchymal stem cells
• Neuronal cells - direct conversion

Differentiation Protocols

Neural Differentiation

Embryoid Body Formation → Neural Rosette Selection → Neural Progenitor Expansion → Neuronal Maturation → Subtype Specification [@sances2016]

Dopaminergic Neurons

• Midbrain specification - SHH, FGF8, Wnt inhibition
• Floor plate method - LMX1A, FOXA2 expression
• Floor plate-derived - authentic midbrain identity

Motor Neurons

• Retinoic acid - caudalization
• SHH - ventral patterning
• V2 interneurons - V2A specification
• Cholinergic specification - choline acetyltransferase

Cortical Neurons

• Dual-SMAD inhibition - cortical identity
• Pax6 - radial glia specification
• TBR2 - intermediate progenitor
• CTIP2 - deep layer neurons

Disease Modeling Applications

Alzheimer's Disease Models

Amyloid Pathology

• Patient-derived neurons show Aβ42 secretion
• Elevated Aβ40/Aβ42 ratio
• Rescue with BACE inhibitors

Tau Pathology

• Hyperphosphorylated tau accumulation
• NFT-like formations
• Tau spread mechanisms

Phenotypic Screens

• Drug candidate testing
• Genetic modifier identification
• Mechanism of action studies

Parkinson's Disease Models

α-Synuclein

• Lewy body-like inclusions
• Progressive aggregation
• Spreading in neurons

Mitochondrial Dysfunction

• Complex I deficiency
• PINK1/Parkin pathway
• mtDNA mutations

LRRK2 Studies

• G2019S knock-in models
• Kinase hyperactivity
• Drug sensitivity testing

Amyotrophic Lateral Sclerosis Models

TDP-43 Pathology

• Cytoplasmic mislocalization
• Aggregation
• Splicing defects

C9orf72 Studies

• Hexanucleotide repeat expansion
• DPR protein toxicity
• RNA foci formation

Motor Neuron Survival

• Patient-derived motor neurons
• Drug screening platforms
• Gene editing rescue

Other Neurodegenerative Conditions

• Huntington's Disease - mutant huntingtin
• Frontotemporal Dementia - tau, TDP-43
• Spinal Muscular Atrophy - SMN deficiency
• Friedreich's Ataxia - frataxin deficiency

Therapeutic Applications

Cell Replacement Therapy

Advantages

• Patient-specific (autologous)
• Immune-matched
• Disease-causing mutations correctable

Challenges

• Tumorigenicity risk
• Functional maturation
• Integration and connectivity
• Scalable production

Clinical Trials

Drug Discovery

Patient-Specific Platforms

• Personalized medicine
• Genotype-phenotype correlation
• Resistance mechanisms

High-Throughput Screening

• FDA-approved drug repurposing
• Novel compound testing
• Toxicity prediction

Genetic Correction

CRISPR-Cas9 Applications

• Point mutations - base editing
• Repeat expansions - deletion/reduction
• Gene knock-in - reporters, corrections

Isogenic Controls

• Patient iPSCs vs gene-corrected
• Isogenic lines for disease modeling
• Background control for screening

Challenges and Limitations

Technical Challenges

• Genetic stability - chromosomal abnormalities
• Epigenetic memory - incomplete reprogramming
• Variability - line-to-line differences
• Maturation - fetal-like vs adult state

Practical Challenges

• Cost and time (6-12 months)
• Manufacturing scale-up
• Quality control
• Regulatory pathways

Safety Concerns

• Tumor formation (teratomas)
• Genetic mutations
• Immunogenicity
• Functional deficits

See Also

• [Stem Cells
• [Neural Stem Cells](/cell-types/subventricular-zone-neural-stem-cells)
• [Embryonic Stem Cells](/technologies/stem-cells)
• Disease Modeling
• [Gene Editing](/diseases/stem-cells](/content/diseases)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)

Overview

Ipsc Derived Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Ipsc Derived Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Pathway Diagram

The following diagram shows the key molecular relationships involving iPSC-Derived Neurons discovered through SciDEX knowledge graph analysis: